Symbiox Investment & Trading Co. Ltd.
Bombay Stock ExchangeTotal Valuation
Symbiox Investment & Trading Co. Ltd. carries a market capitalization of 47.56M, placing it among publicly traded companies globally. Its enterprise value stands at -121.80M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 47.56M |
| Enterprise Value | -121.80M |
Share Statistics
Symbiox Investment & Trading Co. Ltd. currently has 31.29M shares outstanding.
| Shares Outstanding | 31.29M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Symbiox Investment & Trading Co. Ltd. trades at a trailing price-to-earnings ratio of 29.81. The price-to-sales ratio is 2.83, and the price-to-book ratio stands at 0.15.
| PE Ratio | 29.81 |
| PS Ratio | 2.83 |
| PB Ratio | 0.15 |
| P/TBV Ratio | 0.14 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 5.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 25.22 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.67 |
| EV / EBITDA | 25.22 |
| EV / EBIT | 25.22 |
| EV / FCF | N/A |
Financial Position
Symbiox Investment & Trading Co. Ltd. maintains a current ratio of 320.60, meaning it holds 320.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 320.60 |
| Quick Ratio | 167.71 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
Symbiox Investment & Trading Co. Ltd. posts a return on equity of 0.48 and a return on invested capital of 0.47.
| Return on Equity (ROE) | 0.48 |
| Return on Assets (ROA) | 0.48 |
| Return on Invested Capital (ROIC) | 0.47 |
| Return on Capital Employed (ROCE) | 0.48 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.04 |
Taxes
Over the trailing twelve months, Symbiox Investment & Trading Co. Ltd. has paid 535,000.00 in income taxes, reflecting an effective tax rate of 26.00.
| Income Tax | 535,000.00 |
| Effective Tax Rate | 26.00 |
Stock Price Statistics
Symbiox Investment & Trading Co. Ltd.'s stock has declined approximately -43.91144% over the past 52 weeks. The 50-day moving average sits at 1.72, while the 200-day moving average is 2.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | -43.91144% |
| 50-Day Moving Average | 1.72 |
| 200-Day Moving Average | 2.12 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Symbiox Investment & Trading Co. Ltd. generated 16.03M in revenue and converted that into 1.52M in net income, yielding earnings per share of 0.05. EBITDA reached 2.04M, while operating income came in at 2.04M.
| Revenue | 16.03M |
| Gross Profit | 6.04M |
| Operating Income | 2.04M |
| Pretax Income | 2.06M |
| Net Income | 1.52M |
| EBITDA | 2.04M |
| EBIT | 2.04M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
Total book value stands at 312.87M, with working capital of 318.64M providing operational flexibility.
| Cash & Cash Equivalents | 167.20M |
| Total Debt | N/A |
| Net Debt | -2.66M |
| Equity (Book Value) | 312.87M |
| Book Value Per Share | 10.06 |
| Working Capital | 318.64M |
Margins
Symbiox Investment & Trading Co. Ltd. operates with a gross margin of 37.66, reflecting its pricing power and cost economics. The operating margin of 12.70 and net profit margin of 9.50 provide insight into operational efficiency.
| Gross Margin | 37.66 |
| Operating Margin | 12.70 |
| Pretax Margin | 12.84 |
| Profit Margin | 9.50 |
| EBITDA Margin | 12.70 |
Scores
Symbiox Investment & Trading Co. Ltd. posts an Altman Z-Score of 28.59, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 28.59 |